PDS Planning Inc Buys 204 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

PDS Planning Inc lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,589 shares of the medical equipment provider’s stock after buying an additional 204 shares during the period. PDS Planning Inc’s holdings in Intuitive Surgical were worth $787,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Castleark Management LLC increased its position in shares of Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after purchasing an additional 2,990 shares during the last quarter. Ewing Morris & Co. Investment Partners Ltd. bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $454,000. Whalerock Point Partners LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $209,000. Tounjian Advisory Partners LLC bought a new position in Intuitive Surgical in the first quarter worth approximately $5,152,000. Finally, Brighton Jones LLC boosted its stake in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $521.63 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The business has a 50 day simple moving average of $530.03 and a two-hundred day simple moving average of $536.86. The stock has a market capitalization of $186.96 billion, a PE ratio of 76.49, a P/E/G ratio of 5.55 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period last year, the firm posted $1.50 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on ISRG shares. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 23rd. Truist Financial lowered their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Barclays reduced their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Finally, Robert W. Baird lowered their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $588.95.

Insiders Place Their Bets

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the firm’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares of the company’s stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock valued at $2,611,577 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.